|
1.
|
|
5 p, 792.2 KB |
The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease
/
Geraldes, Ruth (Nuffield Department of Clinical Neurosciences) ;
Juryńczyk, Maciej (Nuffield Department of Clinical Neurosciences) ;
dos Passos, Giordani Rodrigues (Nuffield Department of Clinical Neurosciences) ;
Pichler, Alexander (Medical University of Graz. Department of Neurology) ;
Chung, Karen (University College London Institute of Neurology) ;
Hagens, Marloes (Vrije Universiteit Amsterdam. Department of Neurology) ;
Ruggieri, Serena (San Camillo Forlanini Hospital) ;
Auger, Cristina (Hospital Universitari Vall d'Hebron) ;
Sastre-Garriga, Jaume (Hospital Universitari Vall d'Hebron) ;
Enzinger, Christian (Medical University of Graz. Department of Neurology) ;
Chard, Declan (University College London. Institute of Neurology) ;
Barkhof, Frederik (Vrije Universiteit Amsterdam. Department of Radiology and Nuclear Medicine) ;
Gasperini, Claudio (San Camillo Forlanini Hospital) ;
Rovira, Alex (Hospital Universitari Vall d'Hebron) ;
DeLuca, Gabriele (Nuffield Department of Clinical Neurosciences) ;
Palace, Jacqueline (Nuffield Department of Clinical Neurosciences) ;
Universitat Autònoma de Barcelona
Differentiating multiple sclerosis (MS) from vascular risk factor (VRF)-small vessel disease (SVD) can be challenging. In order to determine whether or not pontine lesion location is a useful discriminator of MS and VRF-SVD, we classified pontine lesions on brain magnetic resonance imaging (MRI) as central or peripheral in 93 MS cases without VRF, 108 MS patients with VRF and 43 non-MS cases with VRF. [...]
2020 -  10.1177/1352458520943777
Multiple sclerosis, Vol. 27 Núm. 6 (2021) , p. 968-972
|
|
|
2.
|
|
9 p, 147.5 KB |
International Consensus Guidance for Management of Myasthenia Gravis
/
Narayanaswami, Pushpa (Beth Israel Deaconess Medical Center/Harvard Medical School) ;
Sanders, Donald B. (Boston, MA; Department of Neurology) ;
Wolfe, Gil (Duke University Medical Center, Durham, NC; Department of Neurology) ;
Benatar, Michael (Univ. at Buffalo Jacobs School of Medicine and Biomedical Sciences, State University of New York, Buffalo, NY; Department of Neurology) ;
Cea, Gabriel (University of Miami, Miller School of Medicine. Miami, FL) ;
Evoli, Amelia (Dipartimento di Neuroscienze, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy) ;
Gilhus, Nils Erik (Department of Clinical Medicine, University of Bergen, Norway) ;
Illa, Isabel (Institut d'Investigació Biomèdica Sant Pau) ;
Kuntz, Nancy L. (Departments of Pediatrics and Neurology, Northwestern Feinberg School of Medicine, Chicago, IL) ;
Massey, Janice (Boston, MA; Department of Neurology) ;
Melms, Arthur (Neurology, University of Tübingen Medical Centre, Tübingen, Germany) ;
Murai, Hiroyuki (Department of Neurology, International University of Health and Welfare, Narita, Japan) ;
Nicolle, Michael (Department of Clinical Neurological Sciences, Western University, London, ON, Canada) ;
Palace, Jacqueline (John Radcliffe Hospital (Oxford, Regne Unit)) ;
Richman, David (department of Neurology, University of California, Davis, Davis, CA) ;
Verschuuren, Jan (Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands) ;
Universitat Autònoma de Barcelona
To update the 2016 formal consensus-based guidance for the management of myasthenia gravis (MG) based on the latest evidence in the literature. In October 2013, the Myasthenia Gravis Foundation of America appointed a Task Force to develop treatment guidance for MG, and a panel of 15 international experts was convened. [...]
2021 - 10.1212/WNL.0000000000011124
Neurology, Vol. 96 (january 2021) , p. 114-122
|
|
|
3.
|
|
9 p, 359.6 KB |
The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations
/
Rodríguez Cruz, Pedro M. (John Radcliffe Hospital (Oxford, Regne Unit)) ;
Cossins, Judith (Neurosciences Group. Nuffield Department of Clinical Neurosciences. Weatherall Institute of Molecular Medicine. University of Oxford) ;
De Paula Estephan, Eduardo (Departamento de Neurologia. Faculdade de Medicina. Universidade de São Paulo (FMUSP)) ;
Munell Casadesus, Francina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Selby, KKathryn (University of British Columbia) ;
Hirano, Michio (Department of Neurology. H. Houston Merritt Neuromuscular Research Center. Columbia University Medical Center) ;
Maroofin, Reza (Molecular and Clinical Sciences Institute. St. George's. University of London) ;
Mehrjardi, Mohammad Yahya Vahid (Medical Genetics Research Centre. Shahid Sadoughi University of Medical Sciences) ;
Chow, Gabriel (Nottingham University Hospitals NHS Trust (Regne Unit)) ;
Carr, Aislin (MRC Centre for Neuromuscular Diseases. National Hospital for Neurology and Neurosurgery) ;
Manzur, Adnan (Dubowitz Neuromuscular Centre. MRC Centre for Neuromuscular Diseases. UCL Great Ormond Street Institute of Child Health) ;
Robb, Stephanie (Dubowitz Neuromuscular Centre. MRC Centre for Neuromuscular Diseases. UCL Great Ormond Street Institute of Child Health) ;
Munot, Pinki (Dubowitz Neuromuscular Centre. MRC Centre for Neuromuscular Diseases. UCL Great Ormond Street Institute of Child Health) ;
Wei Liu, Wei (Neurosciences Group. Nuffield Department of Clinical Neurosciences. Weatherall Institute of Molecular Medicine. University of Oxford) ;
Banka, Siddharth (Manchester Centre for Genomic Medicine. St Mary's Hospital. Manchester University NHS Foundation Trust. Health Innovation Manchester) ;
Fraser, Harry (Manchester Centre for Genomic Medicine. St Mary's Hospital. Manchester University NHS Foundation Trust. Health Innovation Manchester) ;
De Goede, Christian (Department of Paediatric Neurology. Royal Preston Hospital) ;
Zanoteli, Edmar (Departamento de Neurologia. Faculdade de Medicina. Universidade de São Paulo (FMUSP)) ;
Conti Reed, Umbertina (Departamento de Neurologia. Faculdade de Medicina. Universidade de São Paulo (FMUSP)) ;
Sage, Abigail (Department of Neurology. H. Houston Merritt Neuromuscular Research Center. Columbia University Medical Center) ;
Gratacòs-Viñola, Margarida (Hospital Universitari Vall d'Hebron) ;
Macaya Ruiz, Alfons (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Dusl, Marina (Friedrich-Baur-Institute. Department of Neurology. University Hospital LMU Munich) ;
Senderek, Jan (Friedrich-Baur-Institute. Department of Neurology. University Hospital LMU Munich) ;
Töpf, Ana (Institute of Genetic Medicine) ;
Hofer, Monika (John Radcliffe Hospital (Oxford, Regne Unit)) ;
Knight, Ravi (John Radcliffe Hospital (Oxford, Regne Unit)) ;
Ramdas, Sithara (Department of Paediatric Neurology. John Radcliffe Hospital NHS Foundation Trust) ;
Jayawant, Sandeep (Department of Paediatric Neurology. John Radcliffe Hospital NHS Foundation Trust) ;
Lochmüller, Hans (Division of Neurology. Department of Medicine. Ottawa Hospital) ;
Palace, Jacqueline (John Radcliffe Hospital (Oxford, Regne Unit)) ;
Beeson, David (Neurosciences Group. Nuffield Department of Clinical Neurosciences. Weatherall Institute of Molecular Medicine. University of Oxford) ;
Universitat Autònoma de Barcelona
Next generation sequencing techniques were recently used to show mutations in COL13A1 cause synaptic basal lamina-associated congenital myasthenic syndrome type 19. Animal studies showed COL13A1, a synaptic extracellular-matrix protein, is involved in the formation and maintenance of the neuromuscular synapse that appears independent of the Agrin-LRP4-MuSK-DOK7 acetylcholine receptor clustering pathway. [...]
2019 - 10.1093/brain/awz107
Brain, Vol. 142 Núm. 6 (january 2019) , p. 1547-1560
|
|
|
4.
|
|
7 p, 189.2 KB |
International consensus guidance for management of myasthenia gravis
/
Sanders, Donald B. (Duke University Medical Center) ;
Wolfe, Gil I. (Duke University Medical Center) ;
Benatar, Michael (University at Buffalo School of Medicine and Biomedical Sciences, State University of New York; Department of Neurology) ;
Evoli, Amelia (University of Miami, Miller School of Medicine (FL, Estats Units d'Amèrica). Department of Neurology) ;
Gilhus, Nils E. (Catholic University (Roma, Itàlia). Department of Clinical Medicine) ;
Illa, Isabel (Institut d'Investigació Biomèdica Sant Pau) ;
Massey, Janice M. (Duke University Medical Center) ;
Kuntz, Nancy (Duke University Medical Center) ;
Melms, Arthur (Northwestern Feinberg School of Medicine (Chicago, Estats Units d'Amèrica)) ;
Murai, Hiroyuki (University of Tübingen (Alemanya). Department of Neurological Therapeutics) ;
Nicolle, Michael (Kyushu University (Fukuoka, Japó). Department of Clinical Neurological Sciences) ;
Palace, Jacqueline (Western University (London, Canadà). Department of Clinical Neurology) ;
Richman, David P. (John Radcliffe Hospital (Oxford, Regne Unit)) ;
Verschuuren, Jan (University of California (Davis, Estats Units d'Amèrica). Department of Neurology) ;
Narayanaswami, Pushpa (Leiden University Medical Centre) ;
Universitat Autònoma de Barcelona
To develop formal consensus-based guidance for the management of myasthenia gravis (MG). In October 2013, the Myasthenia Gravis Foundation of America appointed a Task Force to develop treatment guidance for MG, and a panel of 15 international experts was convened. [...]
2016 - 10.1212/WNL.0000000000002790
Neurology, Vol. 87 (july 2016) , p. 419-425
|
|
|
5.
|
|
11 p, 1.3 MB |
Multicentre comparison of a diagnostic assay : aquaporin-4 antibodies in neuromyelitis optica
/
Waters, Patrick (University of Oxford) ;
Reindl, Markus (Medical University of Innsbruck) ;
Saiz, Albert (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Schanda, Kathrin (Medical University of Innsbruck) ;
Tuller, Friederike (Medical University of Innsbruck) ;
Kral, Vlastimil (Zdravotni ustav se sidlem v Usti nad Labem, Centrum imunologie a mikrobiologie) ;
Nytrova, Petra (Charles University. Faculty of Medicine in Hradec Králové) ;
Sobek, Ondrej (Topelex Ltd) ;
Nielsen, Helle Hvilsted (Odense University Hospital (Dinamarca)) ;
Barington, Torben (Odense University Hospital (Dinamarca)) ;
Lillevang, Søren T. (Odense University Hospital (Dinamarca)) ;
Illes, Zsolt (University of Pécs) ;
Rentzsch, Kristin (Euroimmun AG) ;
Berthele, Achim (Klinikum rechts der Isar der TU München, Klinik für Neurologie) ;
Berki, Tímea (University of Pécs) ;
Granieri, Letizia (Neuroscience Institute Cavalieri Ottolenghi (NICO), University Hospital San Luigi Gonzaga, Regional Referring Multiple Sclerosis Centre) ;
Bertolotto, Antonio (Neuroscience Institute Cavalieri Ottolenghi (NICO), University Hospital San Luigi Gonzaga, Regional Referring Multiple Sclerosis Centre) ;
Giometto, Bruno (Azienda ULSS 9 Treviso) ;
Zuliani, Luigi (Azienda ULSS 9 Treviso) ;
Hamann, Dörte (Sanquin Diagnostic Services, Department of Immunopathology and Blood Coagulation, Amsterdam) ;
van Pelt, E. Daniëlle (MS Centre ErasMS, Erasmus MC) ;
Hintzen, Rogier (MS Centre ErasMS, Erasmus MC) ;
Höftberger, Romana (Medical University of Vienna. Institute of Neurology) ;
Costa, Carme (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Comabella, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Tintoré, Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Siva, Aksel (Istanbul University, Cerrahpasa Medical School) ;
Altintas, Ayse (Istanbul University, Cerrahpasa Medical School) ;
Deniz, Günnur (Istanbul University, Institute of Experimental Medicine) ;
Woodhall, Mark (University of Oxford) ;
Palace, Jacqueline (University of Oxford) ;
Paul, Friedemann (Charité - Universitätsmedizin Berlin) ;
Hartung, Hans-Peter (Heinrich-Heine-University Düsseldorf) ;
Aktas, Orhan (Heinrich-Heine-University Düsseldorf) ;
Jarius, Sven (University of Heidelberg) ;
Wildemann, Brigitte (University of Heidelberg) ;
Vedeler, Christian (Haukeland University Hospital (Bergen, Noruega)) ;
Ruiz, Anne (Lyon Neurosciences Research Centre, Neuro-inflammation and Neuro-oncology Team) ;
Leite, M. Isabel (University of Oxford) ;
Trillenberg, Peter (Universitätsklinikum Schleswig-Holstein (Alemanya)) ;
Probst, Monika (Institute for Quality Assurance) ;
Saschenbrecker, Sandra (Euroimmun AG) ;
Vincent, Angela (University of Oxford) ;
Marignier, Romain (Lyon Neurosciences Research Centre, Neuro-inflammation and Neuro-oncology Team) ;
Universitat Autònoma de Barcelona
Antibodies to cell surface central nervous system proteins help to diagnose conditions which often respond to immunotherapies. The assessment of antibody assays needs to reflect their clinical utility. [...]
2016 - 10.1136/jnnp-2015-312601
Journal of Neurology, Neurosurgery, and Psychiatry, Vol. 87 (april 2016) , p. 1005-1015
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
